Evidence map›Paper›PMID 29781587›Full record

ArticleArthritis care & research2019

Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms.

Eldin Dzubur, Carine Khalil, Christopher V Almario, Benjamin Noah, Deeba Minhas, Mariko Ishimori, Corey Arnold, Yujin Park, Jonathan Kay, Michael H Weisman and 1 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Arthritis care & research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06905288 (Real-world Observational Study to Evaluate the Effectiveness of Secukinumab in Biologic-naive Ankylosing Spondylitis Patients in Korea), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06905288 recruitingnot on this mapstarted 2025, after this paper: background citation

Real-world Observational Study to Evaluate the Effectiveness of Secukinumab in Biologic-naive Ankylosing Spondylitis Patients in Korea

TypeobservationalSponsorNovartis PharmaceuticalsRan2025 to 2026Enrolled70ConditionsAnkylosing SpondylitisArmsSecukinumab
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Patients' perspectives on irritable bowel syndrome: a qualitative analysis based on social media in China.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Eldin DzuburCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0002-3248-5327
Carine KhalilCedars-Sinai Medical Center and Cedars-Sinai Center for Outcomes Research and Education, Los Angeles, California.ORCID 0000-0001-5071-0500
Christopher V AlmarioCedars-Sinai Medical Center and Cedars-Sinai Center for Outcomes Research and Education, Los Angeles, California.ORCID 0000-0003-0664-9479
Benjamin NoahCedars-Sinai Medical Center and Cedars-Sinai Center for Outcomes Research and Education, Los Angeles, California.ORCID 0000-0002-1730-9616
Deeba MinhasCedars-Sinai Medical Center, Los Angeles, California.
Mariko IshimoriCedars-Sinai Medical Center, Los Angeles, California.
Corey ArnoldMedical Imaging Informatics, University of California, Los Angeles.ORCID 0000-0002-4119-8143
Yujin ParkNovartis Pharmaceuticals Corporation, East Hanover, New Jersey.ORCID 0000-0003-0463-4329
Jonathan KayUniversity of Massachusetts Memorial Medical Center and University of Massachusetts Medical School, Worcester.ORCID 0000-0002-8970-4260
Michael H WeismanCedars-Sinai Medical Center, Los Angeles, California.ORCID 0000-0001-5568-388X
Brennan M R SpiegelCedars-Sinai Medical Center and Cedars-Sinai Center for Outcomes Research and Education, Los Angeles, California.ORCID 0000-0002-4608-6896
Cedars-Sinai Medical Center · USNovartis (United States) · USUniversity of California, Los Angeles · USUniversity of Massachusetts Chan Medical School · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
American College of GastroenterologyMarc and Sheri Rapaport Fund for Digital Health Sciences and Precision HealthNCATS NIH HHS UL1 TR001881Novartis Pharmaceuticals Corporation
6 · The paper itself

Abstract

objectiveFew studies have examined ankylosing spondylitis (AS) patients' concerns about and perceptions of biologic therapies, apart from traditional surveys. In this study, we used social media data to examine the knowledge, attitudes, and beliefs of AS patients regarding biologic therapies.

methodsWe collected posts published on 601 social media sites between January 1, 2016 and April 26, 2017. In each post, both an AS keyword and a biologic were mentioned. To explore themes within the collection of posts in an unsupervised manner, a latent Dirichlet allocation topic model was fit to the data set. Each discovered topic was represented as a discrete distribution over the words in the collection, similar to a word cloud. The topics were manually reviewed to identify themes, which were confirmed using thematic data analysis.

resultsWe examined 27,416 social media posts and identified 112 themes. The majority of themes (n = 67 [60%]) focused on discussions related to AS treatment. Other themes, including the psychological impact of AS, reporting of medical literature, and AS disease consequences, accounted for the remaining 40% (n = 45). In discussions regarding AS treatment, most topics involved biologics, and most subthemes involved side effects (e.g., fatigue, allergic reactions), biologic treatment attributes (e.g., dosing, frequency), and concerns about use of biologics (e.g., increased cancer risk). Additional implicit patient needs (e.g., support) were identified using qualitative analyses.

conclusionSocial media revealed a dynamic range of themes governing AS patients' experience with and choice of biologic agents. The complexity of selecting biologics from among many such agents and navigating their risk/benefit profiles suggests the merit of creating online tools tailored to support patients' decision-making with regard to biologic therapies for AS.

Indexed as

Surveys and QuestionnairesBiological TherapyData MiningHumansPatient ParticipationSocial MediaSpondylitis, Ankylosing

Identifiers

PMID29781587
PMCPMC6946060
OpenAlexW2804174285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.